These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8985276)
21. [Laboratory findings and serum levels of amyloid A and soluble interleukin-2 receptors in patients with renal amyloidosis]. Rysavá R; Merta M; Tesar V; Zabka J; Spicka I; Stejskalová A; Vernerová Z Cas Lek Cesk; 1998 Feb; 137(4):107-9. PubMed ID: 9531732 [TBL] [Abstract][Full Text] [Related]
22. Primary AL (kappa-light chain) amyloidosis manifesting as peripheral neuropathy in a young male without increase in serum and urine immunoglobulin load: a diagnostic challenge. Sarkar C; Chand Sharma M; Nayak A; Mercy Ralte A; Gupta V; Singh S; Behari M Clin Neuropathol; 2005; 24(3):118-25. PubMed ID: 15943163 [TBL] [Abstract][Full Text] [Related]
23. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation. Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449 [TBL] [Abstract][Full Text] [Related]
24. Primary amyloidosis presenting as intrahepatic cholestasis. Bandyopadhyay SK; Bandyopadhyay R; Dutta A Indian J Pathol Microbiol; 2006 Oct; 49(4):557-9. PubMed ID: 17183853 [TBL] [Abstract][Full Text] [Related]
25. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity. Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526 [TBL] [Abstract][Full Text] [Related]
26. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Maurer MS; Raina A; Hesdorffer C; Bijou R; Colombo P; Deng M; Drusin R; Haythe J; Horn E; Lee SH; Marboe C; Naka Y; Schulman L; Scully B; Shapiro P; Prager K; Radhakrishnan J; Restaino S; Mancini D Transplantation; 2007 Mar; 83(5):539-45. PubMed ID: 17353770 [TBL] [Abstract][Full Text] [Related]
27. Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features. Caballería J; Bruguera M; Solé M; Campistol JM; Rodés J Am J Gastroenterol; 2001 Jun; 96(6):1872-6. PubMed ID: 11419842 [TBL] [Abstract][Full Text] [Related]
28. Renal amyloidosis followed more than 5 years: report of 12 cases. Kaaroud H; Boubaker K; Béji S; Abderrahim E; Moussa FB; Turki S; Goucha R; Hedri H; El Younsi F; Kheder A; Maiz HB Transplant Proc; 2004; 36(6):1796-8. PubMed ID: 15350480 [TBL] [Abstract][Full Text] [Related]
29. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357 [TBL] [Abstract][Full Text] [Related]
30. Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test? Ansari-Lari MA; Ali SZ Diagn Cytopathol; 2004 Mar; 30(3):178-81. PubMed ID: 14986298 [TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal manifestations of amyloidosis. Ebert EC; Nagar M Am J Gastroenterol; 2008 Mar; 103(3):776-87. PubMed ID: 18076735 [TBL] [Abstract][Full Text] [Related]
32. A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an Eastern Cooperative Oncology Group Study. Gertz MA; Blood E; Vesole DH; Abonour R; Lazarus HM; Greipp PR Bone Marrow Transplant; 2004 Jul; 34(2):149-54. PubMed ID: 15156165 [TBL] [Abstract][Full Text] [Related]
33. A noninvasive screening of systemic reactive (secondary) AA amyloidosis, based on reduced amyloid degrading activity of amyloidotic serum. Ravid M; Greenman Y; Shapira J; Kedar I Isr J Med Sci; 1990 Apr; 26(4):191-4. PubMed ID: 2347684 [TBL] [Abstract][Full Text] [Related]
34. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Gertz MA; Kyle RA Am J Med; 1988 Jul; 85(1):73-80. PubMed ID: 3389383 [TBL] [Abstract][Full Text] [Related]
36. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. Husby G; Natvig JB J Clin Invest; 1974 Apr; 53(4):1054-61. PubMed ID: 4205522 [TBL] [Abstract][Full Text] [Related]
37. Secondary amyloidosis in rhesus monkeys with chronic indwelling venous catheters. Doepel FM; Ringler DH; Petkus AR Lab Anim Sci; 1984 Oct; 34(5):494-6. PubMed ID: 6513513 [TBL] [Abstract][Full Text] [Related]
38. Detection of systemic amyloidosis in the pig-tailed macaque (Macaca nemestrina). Hukkanen RR; Liggitt HD; Anderson DM; Kelley ST Comp Med; 2006 Apr; 56(2):119-27. PubMed ID: 16639979 [TBL] [Abstract][Full Text] [Related]
39. Hepatic amyloidosis--two cases report. Jeong HJ; Hahn EK; Kim E; Park CI J Korean Med Sci; 1988 Dec; 3(4):151-5. PubMed ID: 3267363 [TBL] [Abstract][Full Text] [Related]
40. Extremely high levels of serum alkaline phosphatase in patients with prolonged hepatic congestion. Mshe'el S; Bisharat N Eur J Gastroenterol Hepatol; 2011 May; 23(5):444. PubMed ID: 21490484 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]